Page last updated: 2024-08-17

carbostyril and Nerve Degeneration

carbostyril has been researched along with Nerve Degeneration in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Choudhary, M; Malek, G1
Bassani, C; Colombo, E; Comi, G; De Angelis, A; Farina, C; Martino, G; Ottoboni, L; Pascente, R; Ruffini, F; Triolo, D1
Boyce, S; Carlson, E; Hill, RG; Martin, JE; Rupniak, NM; Webb, JK1

Reviews

1 review(s) available for carbostyril and Nerve Degeneration

ArticleYear
The Aryl Hydrocarbon Receptor: A Mediator and Potential Therapeutic Target for Ocular and Non-Ocular Neurodegenerative Diseases.
    International journal of molecular sciences, 2020, Sep-16, Volume: 21, Issue:18

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Biotransformation; Central Nervous System; Cytochrome P-450 Enzyme System; Disease Models, Animal; Eye Diseases; Eye Proteins; Gene Expression Regulation; Helix-Loop-Helix Motifs; Humans; Ligands; Mammals; Molecular Targeted Therapy; Multiple Sclerosis; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; Polychlorinated Dibenzodioxins; Quinolones; Rats; Receptors, Aryl Hydrocarbon; Signal Transduction; Transcription, Genetic; Xenobiotics

2020

Other Studies

2 other study(ies) available for carbostyril and Nerve Degeneration

ArticleYear
Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during Inflammation.
    Molecules (Basel, Switzerland), 2020, Nov-18, Volume: 25, Issue:22

    Topics: Amino Acid Transport System X-AG; Animals; Astrocytes; Humans; Induced Pluripotent Stem Cells; Inflammation; Interleukin-1beta; Nerve Degeneration; Neurotoxins; NF-kappa B; Quinolones; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Signal Transduction

2020
Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.
    Experimental neurology, 1999, Volume: 155, Issue:1

    Topics: Animals; Disease Progression; Excitatory Amino Acid Antagonists; Female; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Motor Activity; Motor Neuron Disease; Nerve Degeneration; Quinolones; Selegiline; Stereoisomerism

1999